Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease.

Ekström M, Bornefalk H, Sköld M, Janson C, Blomberg A, Sandberg J, Bornefalk-Hermansson A, Igelström H, Sundh J.

BMJ Open Respir Res. 2019 Sep 18;6(1):e000381. doi: 10.1136/bmjresp-2018-000381. eCollection 2019.

2.

Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.

Sundh J, Bornefalk H, Sköld CM, Janson C, Blomberg A, Sandberg J, Bornefalk-Hermansson A, Igelström H, Ekström M.

BMJ Open Respir Res. 2019 Sep 18;6(1):e000418. doi: 10.1136/bmjresp-2019-000418. eCollection 2019.

3.

Factors associated with well-controlled asthma-A cross-sectional study.

Lindgren H, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.

Allergy. 2019 Jul 12. doi: 10.1111/all.13976. [Epub ahead of print] No abstract available.

PMID:
31298735
4.

Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease.

Åberg J, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.

Int J Chron Obstruct Pulmon Dis. 2019 May 7;14:961-969. doi: 10.2147/COPD.S193311. eCollection 2019.

5.

Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application.

Sandberg J, Lansing R, Anderberg P, Currow D, Sundh J, Ahmadi Z, Palmqvist S, Ekström M.

BMJ Open Respir Res. 2019 Feb 12;6(1):e000370. doi: 10.1136/bmjresp-2018-000370. eCollection 2019.

6.

REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol.

Sundh J, Bornefalk-Hermansson A, Ahmadi Z, Blomberg A, Janson C, Currow DC, McDonald CF, McCaffrey N, Ekström M.

BMC Pulm Med. 2019 Feb 26;19(1):50. doi: 10.1186/s12890-019-0809-7.

7.

Effectiveness trials: critical data to help understand how respiratory medicines really work?

Heddini A, Sundh J, Ekström M, Janson C.

Eur Clin Respir J. 2019 Jan 29;6(1):1565804. doi: 10.1080/20018525.2019.1565804. eCollection 2019. Review.

8.

Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.

Giezeman M, Hasselgren M, Lisspers K, Ställberg B, Montgomery S, Janson C, Sundh J.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 28;13:3857-3865. doi: 10.2147/COPD.S175641. eCollection 2018.

9.

Prevalent reliance of bacterioplankton on exogenous vitamin B1 and precursor availability.

Paerl RW, Sundh J, Tan D, Svenningsen SL, Hylander S, Pinhassi J, Andersson AF, Riemann L.

Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10447-E10456. doi: 10.1073/pnas.1806425115. Epub 2018 Oct 15.

10.

Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients.

Sundh J, Ahmadi Z, Ekström M.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2623-2628. doi: 10.2147/COPD.S167523. eCollection 2018.

11.

BARM and BalticMicrobeDB, a reference metagenome and interface to meta-omic data for the Baltic Sea.

Alneberg J, Sundh J, Bennke C, Beier S, Lundin D, Hugerth LW, Pinhassi J, Kisand V, Riemann L, Jürgens K, Labrenz M, Andersson AF.

Sci Data. 2018 Jul 31;5:180146. doi: 10.1038/sdata.2018.146.

12.

Further Need for Evidence in Long-Term Oxygen Therapy.

Ekström M, Ahmadi Z, Sundh J.

Ann Am Thorac Soc. 2018 Apr;15(4):511-512. doi: 10.1513/AnnalsATS.201801-023LE. No abstract available.

PMID:
29384689
13.

Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD.

Stegberg M, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.

Eur Clin Respir J. 2018 Jan 4;5(1):1421389. doi: 10.1080/20018525.2017.1421389. eCollection 2018.

14.

Absolute lung size and the sex difference in breathlessness in the general population.

Ekström M, Sundh J, Schiöler L, Lindberg E, Rosengren A, Bergström G, Angerås O, Hedner J, Brandberg J, Bake B, Torén K.

PLoS One. 2018 Jan 5;13(1):e0190876. doi: 10.1371/journal.pone.0190876. eCollection 2018.

15.

Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014.

Sundh J, Åberg J, Hasselgren M, Montgomery S, Ställberg B, Lisspers K, Janson C.

Eur Clin Respir J. 2017 Dec 4;4(1):1409060. doi: 10.1080/20018525.2017.1409060. eCollection 2017.

16.

Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.

Sundh J, Wireklint P, Hasselgren M, Montgomery S, Ställberg B, Lisspers K, Janson C.

Respir Med. 2017 Nov;132:154-160. doi: 10.1016/j.rmed.2017.10.010. Epub 2017 Oct 17.

17.

Compound risk judgment in tasks with both idiosyncratic and systematic risk: The "Robust Beauty" of additive probability integration.

Sundh J, Juslin P.

Cognition. 2018 Feb;171:25-41. doi: 10.1016/j.cognition.2017.10.023. Epub 2017 Nov 2.

PMID:
29102806
18.

Risk factors for developing hypoxic respiratory failure in COPD.

Sundh J, Ekström M.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 20;12:2095-2100. doi: 10.2147/COPD.S140299. eCollection 2017.

19.

Pulmonary rehabilitation in COPD - available resources and utilization in Swedish primary and secondary care.

Sundh J, Lindgren H, Hasselgren M, Montgomery S, Janson C, Ställberg B, Lisspers K.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 8;12:1695-1704. doi: 10.2147/COPD.S135111. eCollection 2017.

20.

Dyspnoea-12: a translation and linguistic validation study in a Swedish setting.

Sundh J, Ekström M.

BMJ Open. 2017 Jun 6;7(5):e014490. doi: 10.1136/bmjopen-2016-014490.

21.

Characterization of secondary care for COPD in Sweden.

Sundh J, Janson C, Johansson G, Lindén A, Löfdahl CG, Sandström T, Larsson K.

Eur Clin Respir J. 2017 Jan 24;4(1):1270079. doi: 10.1080/20018525.2016.1270079. eCollection 2017.

22.

Persistent disabling breathlessness in chronic obstructive pulmonary disease.

Sundh J, Ekström M.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 9;11:2805-2812. eCollection 2016.

23.

Meta-omic analyses of Baltic Sea cyanobacteria: diversity, community structure and salt acclimation.

Celepli N, Sundh J, Ekman M, Dupont CL, Yooseph S, Bergman B, Ininbergs K.

Environ Microbiol. 2017 Feb;19(2):673-686. doi: 10.1111/1462-2920.13592. Epub 2017 Jan 27.

PMID:
27871145
24.

Swedish translation and linguistic validation of the multidimensional dyspnoea profile.

Ekström M, Sundh J.

Eur Clin Respir J. 2016 Nov 8;3:32665. doi: 10.3402/ecrj.v3.32665. eCollection 2016.

25.

Change in health status in COPD: a seven-year follow-up cohort study.

Sundh J, Montgomery S, Hasselgren M, Kämpe M, Janson C, Ställberg B, Lisspers K.

NPJ Prim Care Respir Med. 2016 Oct 20;26:16073. doi: 10.1038/npjpcrm.2016.73.

26.

Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease.

Ahmadi Z, Sundh J, Bornefalk-Hermansson A, Ekström M.

PLoS One. 2016 Sep 20;11(9):e0163293. doi: 10.1371/journal.pone.0163293. eCollection 2016.

27.

Diversity and Expression of Bacterial Metacaspases in an Aquatic Ecosystem.

Asplund-Samuelsson J, Sundh J, Dupont CL, Allen AE, McCrow JP, Celepli NA, Bergman B, Ininbergs K, Ekman M.

Front Microbiol. 2016 Jul 6;7:1043. doi: 10.3389/fmicb.2016.01043. eCollection 2016.

28.

Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.

Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I; UNLOCK Group of the IPCRG.

NPJ Prim Care Respir Med. 2016 Apr 7;26:16010. doi: 10.1038/npjpcrm.2016.10.

29.

Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?

Ekström M, Sundh J, Larsson K.

Expert Rev Respir Med. 2016;10(3):351-62. doi: 10.1586/17476348.2016.1146595. Epub 2016 Feb 16. Review.

PMID:
26808786
30.

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Sandström T, Janson C.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 28;10:2327-34. doi: 10.2147/COPD.S91362. eCollection 2015.

31.

Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population.

Sundh J, Ställberg B, Lisspers K, Kämpe M, Janson C, Montgomery S.

COPD. 2016;13(1):57-65. doi: 10.3109/15412555.2015.1043426. Epub 2015 Sep 14.

PMID:
26367315
32.

Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units.

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Janson C, Sandström T.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 22;10:173-83. doi: 10.2147/COPD.S74645. eCollection 2015.

33.

Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study.

Kämpe M, Lisspers K, Ställberg B, Sundh J, Montgomery S, Janson C.

Eur Clin Respir J. 2014 Sep 12;1. doi: 10.3402/ecrj.v1.24109. eCollection 2014.

34.

Management of COPD exacerbations in primary care: a clinical cohort study.

Sundh J, Österlund Efraimsson E, Janson C, Montgomery S, Ställberg B, Lisspers K.

Prim Care Respir J. 2013 Dec;22(4):393-9. doi: 10.4104/pcrj.2013.00087.

35.

Assessment of COPD in primary care: new evidence supports use of the DOSE index.

Sundh J, Montgomery S, Ställberg B, Lisspers K.

Prim Care Respir J. 2013 Jun;22(2):142-3. doi: 10.4104/pcrj.2013.00050. No abstract available.

36.

What determines immediate use of invasive ventilation in patients with COPD?

Berkius J, Sundh J, Nilholm L, Fredrikson M, Walther SM.

Acta Anaesthesiol Scand. 2013 Mar;57(3):312-9. doi: 10.1111/aas.12049. Epub 2013 Jan 3.

PMID:
23282215
37.

Clinical COPD Questionnaire score (CCQ) and mortality.

Sundh J, Janson C, Lisspers K, Montgomery S, Ställberg B.

Int J Chron Obstruct Pulmon Dis. 2012;7:833-42. doi: 10.2147/COPD.S38119. Epub 2012 Dec 20.

38.

The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.

Sundh J, Janson C, Lisspers K, Ställberg B, Montgomery S.

Prim Care Respir J. 2012 Sep;21(3):295-301. doi: 10.4104/pcrj.2012.00054.

39.

Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire.

Sundh J, Ställberg B, Lisspers K, Montgomery SM, Janson C.

COPD. 2011 Jun;8(3):173-81. doi: 10.3109/15412555.2011.560130. Epub 2011 Apr 22.

PMID:
21513436
40.

Long-term survival according to ventilation mode in acute respiratory failure secondary to chronic obstructive pulmonary disease: a multicenter, inception cohort study.

Berkius J, Sundh J, Nilholm L, Fredrikson M, Walther SM.

J Crit Care. 2010 Sep;25(3):539.e13-8. doi: 10.1016/j.jcrc.2010.02.006. Epub 2010 Apr 8.

PMID:
20381291

Supplemental Content

Support Center